The acute effects of bisoprolol 10 mg i.v., a new beta1-selective adrenoceptor antagonist, on heart rate, mean blood pressure (mBP), glomerular filtration rate (GFR), para-aminohippuric acid clearance (CPAH), sodium clearance, urine volume and plasma renin activity (PRA), were studied in 6 patients with essential hypertension. Heart rate decreased by 23%, mBP remained unchanged, and GFR decreased by 14% and CPAH by 23%. PRA was depressed on average by 25%. Urine volume and sodium clearance also declined by 9 and 13%, respectively, but the changes were not statistically significant. The fall in heart rate was significantly correlated with that in GFR and CPAH. Changes in GFR were correlated significantly with those in CPAH. The acute changes in renal function induced by bisoprolol are considered to be due to a reduction in cardiac output and increased systemic vascular resistance.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Carriere S (1969) Effect of norepinephrine, isoproteronol and adrenergic blockers upon the intrarenal distribution of blood flow. Can J Physiol Pharmacol 47: 199–208
Nies AS, McNeil JS, Schrier RW (1971) Mechanism of increased sodium reabsorption during Propranolol administration. Circulation 44: 596–604
Wilkinson R (1982) Beta-blockers and renal function. Drugs 23: 195–206
Cohn JN (1983) Haemodynamic effects of beta-blockers. Drugs 25 [Suppl 2]: 100–102
Schirmeister J, Decot M, Hallauer W, Willmann H (1966) Beta-Receptoren und renale Haemodynamik des Menschen. Arzneimittelforsch 16: 847–850
Bufano G, Pacentini L (1969) Studio comparativo dell'influenza esercitata da agonisti e antagonisti beta-adrenergici sulla funzione renale dell'uomo normale. Minerva Med 60: 1229–1232
Sullivan JM, Adams DF, Hollenberg NK (1976) Beta-adrenergic blockade in essential hypertension: Reduced renin release despite renal vasoconstriction. Circ Res 39: 532–536
Heierli C, Thoelen H, Radielovic P (1977) Renal function following a single dose of pindolol in hypertensive patients with varying degrees of impairment of renal function. Int J Clin Pharmacol 15: 65–71
Zech P, Pozet N, Labeeuw M, Sassard J, Bernheim J, Pellet M, Traeger J (1976) Acute renal effects of new beta-adrenergic receptor site blocking agents on renal function. Proc Eur Dial Transplant Assoc 12: 203–209
Swainson CP, Robson JS, Goodfellow RM (1980) Effect of beta-adrenergic blockade on renal function during exercise. Seventh Scientific Meeting of ISH, New Orleans
Duchin K, Antonaccio M, Steinbacher T (1978) Novel effects of nadolol, a new beta-adrenoceptor antagonist on renal function: Comparison with Propranolol. Circulation 58: II-183
Hollenberg NK, Adams DF, McKinstry DN, Williams GH, Borucki LJ, Sullivan JM (1979) Beta-adrenoceptor-blocking agents and the kidney: Effect of nadolol and propranolol on renal circulation. Br J Clin Pharmacol 1 [Suppl 2]: 219s–225s
Bianchi C, Bonadio M, Donadio C, Tramonti G, Figus S, Papalexiou P (1976) Acute effects of tolamolol on renal function in hypertensive patients. Experientia 32: 1565–1566
Tattersfield AE, Cragg DJ, Bacon RJ (1984) Assessment of beta-adrenoceptor selectivity of a new beta-adrenoceptor antagonist, bisoprolol, in man. Br J Clin Pharmacol 18: 343–347
Goldring W, Chasis H (1944) Hypertension and hypertensive disease. New York, The Commonwealth Fund
Reubi FC (1963) Clearance tests in clinical medicine. CC Thomas, Springfield, Ill
Vorburger C, Riedwyl H, Reubi FC (1969) Vergleichende Studien zwischen den renalen Clearances von51CR-EDTA, Inulin und Natriumthiosulfat beim Menschen. Klin Wochenschr 47: 415–420
Sealey JE, Gerten-Banes J, Laragh JH (1972) The renin system. Variations in man measured by radioimmuno-assay or bioassay. Kidney Int 1: 240–253
Ulrich M, Frohlich ED, Dustan HP, Page IH (1968) Immediate hemodynamic effects of beta-adrenergic blockade with propranolol in normotensive and hypertensive man. Circulation 37: 411–416
Reubi FC (1978) Role of physical factors in the acute changes in renal function elicited by antihypertensive drugs. Eur J Clin Pharmacol 13: 185–193
Bühler FR, Marbet G, Patel U, Burkart F (1975) Renin-suppressive potency of various beta-adrenergic blocking agents at supine rest and during upright exercise. Clin Sci Mol Med 48: 61s–64s
Bauer JH, Brooks CS, Burch RN (1982) Renal Function and hemodynamic studies in low and normal renin essential hypertension. Arch Int Med 142: 1317–1323
Reubi FC, Vorburger C, Bütikofer E (1970) A comparison of the short-term and long-term hemodynamic effects of antihypertensive drug therapy. In: Conolly ME (ed) Catapres in hypertension. Butterworth, London, p 113–125
Reubi FC (1977) Le retentissement rénal des traitements antihypertenseurs. J Urol Néphrol 83: 296–302
Ibsen H, Sederberg-Olsen P (1973) Changes in glomerular filtration rate during long-term treatment with propranolol in patients with arterial hypertension. Clin Sci 44: 129–134
Waal-Manning HJ (1979) Atenolol and three non-selective beta-blockers in hypertension. Clin Pharmacol Ther 25: 8–18
Bauer JH (1983) Effects of propranolol therapy on renal function and body fluid composition. Arch Intern Med 143: 927–931
Wilkinson R, Stevens IM, Pickering M, Robson V, Hawkins T, Keer DNS, Harry JD (1980) A study of the effects of atenolol and propranolol on renal function in patients with essential hypertension. Br J Clin Pharmacol 10: 51–59
Waal-Manning HJ, Bolli P (1980) Atenolol v. placebo in mild hypertension: Renal, metabolic and stress antipressor effects. Br J Clin Pharmacol 9: 553–560
Rasmussen S, Rasmussen K (1979) Influence of metoprolol alone and in combination with a thiazide diuretic on blood pressure, plasma volume, extracellular volume and glomerular filtration rate in essential hypertension. Europ J Clin Pharmacol 15: 305–310
About this article
Cite this article
Glück, Z., Reubi, F.C. Acute changes in renal function induced by bisoprolol, a new cardioselective beta-blocking agent. Eur J Clin Pharmacol 31, 107–111 (1986). https://doi.org/10.1007/BF00870997
- heart rate
- blood pressure
- renal clearance
- PAH clearance
- glomerular filtration rate
- plasma renin activity